ADVERTISEMENT
  • News
  • New York
  • Technology
  • Culture
  • Entertainment
  • Sport
  • More
    • Politics
    • Lifestyle
    • TV
    • Games
Sunday, June 15, 2025
  • Login
No Result
View All Result
NEWSLETTER
FINCHANNEL
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • Americas
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • lifestyle
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • Americas
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • lifestyle
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE
No Result
View All Result
FINCHANNEL
No Result
View All Result
Home Health&Beauty

Bristol-Myers Squibb Announces New Research Collaboration with Janssen in Immuno-Oncology Focused on Lung Cancer

The FINANCIAL by The FINANCIAL
July 26, 2016
in Health&Beauty
Reading Time: 2 mins read
7
A A
0
Largest genome-wide study of lung cancer susceptibility conducted
Share on FacebookShare on Twitter

The FINANCIAL — Bristol-Myers Squibb Company today announced a new clinical research collaboration with Janssen Biotech, Inc. to evaluate Bristol-Myers Squibb’s Immuno-Oncology (I-O) agent Opdivo (nivolumab) and Janssen’s Live Attenuated Double–Deleted (LADD) Listerial monocytogenes cancer immunotherapy, expressing mesothelin and EGFRvIII (JNJ-64041757), in patients with non-small cell lung cancer (NSCLC).

Opdivo is a human antibody designed to alleviate immune suppression. JNJ-64041757 is designed to induce the local recruitment and activation of innate and adaptive effector cells and expansion of mesothelin-specific T cells. The Phase 2 clinical trial will evaluate the tolerability and clinical activity of the combination of these agents in NSCLC patients.

“We are excited to collaborate with Janssen as we explore how the emerging science of antigen-presentation therapeutics, in combination with Opdivo, can potentially provide a new treatment approach for patients with lung cancer,” said Jean Viallet, M.D., Global Clinical Research Lead, Oncology, Bristol-Myers Squibb.

RelatedPosts

Fullscript vs. Rupa Health: What the Acquisition Means for Providers and Patients

Signs Your Mental Health Is in Trouble and How to Fix It

Packaged bread can be considered ultra-processed foods

As many as 30% of people with insomnia report using alcohol as a sleep aid

Opdivo was the first PD-1 immune checkpoint inhibitor to receive regulatory approval anywhere in the world in July 2014, and currently has regulatory approval in 54 countries including the United States, Japan, and in the European Union, according to Bristol-Myers Squibb.

JNJ-64041757 (previously referred to as ADU-214) is an antigen-presentation therapeutic, based on Live Attenuated Double-Deleted (LADD) Listeria monocytogenes strains engineered to induce an immune response against NSCLC tumors. It is currently in Phase 1 clinical development for lung cancer. Opdivo is indicated for the treatment of patients with NSCLC with progression on or after platinum-based chemotherapy.

See also  Signs Your Mental Health Is in Trouble and How to Fix It

Bristol-Myers Squibb & Immuno-Oncology: Advancing Oncology Research

At Bristol-Myers Squibb, we have a vision for the future of cancer care that is focused on Immuno-Oncology, now considered a major treatment choice alongside surgery, radiation, chemotherapy and targeted therapies for certain types of cancer.

We have a comprehensive clinical portfolio of investigational and approved Immuno-Oncology agents, many of which were discovered and developed by our scientists. Our ongoing Immuno-Oncology clinical program is looking at broad patient populations, across multiple solid tumors and hematologic malignancies, and lines of therapy and histologies, with the intent of powering our trials for overall survival and other important measures like durability of response. We pioneered the research leading to the first regulatory approval for the combination of two Immuno-Oncology agents and continue to study the role of combinations in cancer.

We are also investigating other immune system pathways in the treatment of cancer including CTLA-4, CD-137, KIR, SLAMF7, PD-1, GITR, CSF1R, IDO and LAG-3. These pathways may lead to potential new treatment options – in combination or monotherapy – to help patients fight different types of cancers.

Our collaboration with academia, as well as small and large biotech and pharmaceutical companies, to research the potential of Immuno-Oncology and non-Immuno-Oncology combinations helps achieve our goal of providing new treatment options in clinical practice.

At Bristol-Myers Squibb, we are committed to changing survival expectations in hard-to-treat cancers and the way patients live with cancer.

 

Related Posts

Fullscript vs. Rupa Health: What the Acquisition Means for Providers and Patients
Health&Beauty

Fullscript vs. Rupa Health: What the Acquisition Means for Providers and Patients

by The FINANCIAL
June 11, 2025
0

In a significant move that reshapes the healthcare landscape, Fullscript, a leading healthcare platform for whole person care, announced the...

Read more
Signs Your Mental Health Is in Trouble and How to Fix It

Signs Your Mental Health Is in Trouble and How to Fix It

May 28, 2025
Packaged bread can be considered ultra-processed foods

Packaged bread can be considered ultra-processed foods

April 29, 2025
Chronic sleep deficiency increases insulin resistance in women, especially postmenopausal women

As many as 30% of people with insomnia report using alcohol as a sleep aid

April 16, 2025

Discussion about this post

  • Trending
  • Comments
  • Latest
Ampersand wins £22m five-year contract at London Zoo

Ampersand wins £22m five-year contract at London Zoo

June 25, 2012
Domestic tourism numbers decreased in Georgia

Georgian economy contracted by 5.5 % in July 2020

August 31, 2020
Fullscript vs. Rupa Health: What the Acquisition Means for Providers and Patients

Fullscript vs. Rupa Health: What the Acquisition Means for Providers and Patients

June 11, 2025
Will digital media be decisive in general election – as it was in Donald Trump’s victory? 

How to Align Social Media with Your Overall Marketing Strategy

June 11, 2025
Teaching porn literacy

A sizable percentage of internet porn users, roughly 40% are women

January 17, 2024
REVAZ NATROSHVILI, CEO of Proservice

Proservice Launches Cloud Solutions, Expanding Infrastructure with Innovations

June 14, 2025
ROLAND ERADZE, Founder of Bona Georgia

Bona Georgia Expands with New Showroom and Innovations in Floor Care

June 14, 2025
Foodmg

The Standard of Excellence in Catering: Food Management Group Wins Golden Brand Award

June 14, 2025
RMN02917_sante004_prevs

From France to Georgia: Président Cheese Wins the Golden Brand Award

June 14, 2025
TAMTA KALANDADZE, Brand Manager at BMS

Pasta Reggia Expands Its Footprint in Georgian Market with New Products

June 14, 2025
ADVERTISEMENT

Popular Last 24h

  • Ampersand wins £22m five-year contract at London Zoo

    Ampersand wins £22m five-year contract at London Zoo

    3602 shares
    Share 1441 Tweet 901
  • LiveSupport Expands Global Presence While Innovating in Georgia’s IT Sector

    22 shares
    Share 9 Tweet 6
  • Herbalife: 45 Years of Global Expertise in Balanced Nutrition, 14 Years Fostering the Healthy Lifestyle Community in Georgia

    21 shares
    Share 8 Tweet 5
  • From Shoes to Style: How Geox is Expanding its Footprint in Georgia

    20 shares
    Share 8 Tweet 5
  • Ramos MacShaurma Expands in Georgia with New Fast Food Concepts

    19 shares
    Share 8 Tweet 5
  • First Montessori Kindergarten in Georgia Awarded Golden Brand 

    19 shares
    Share 8 Tweet 5
  • Discover the Healing Power of Khakhabo Natural Oils

    19 shares
    Share 8 Tweet 5

LATEST POSTS

REVAZ NATROSHVILI, CEO of Proservice

Proservice Launches Cloud Solutions, Expanding Infrastructure with Innovations

June 14, 2025
ROLAND ERADZE, Founder of Bona Georgia

Bona Georgia Expands with New Showroom and Innovations in Floor Care

June 14, 2025
Foodmg

The Standard of Excellence in Catering: Food Management Group Wins Golden Brand Award

June 14, 2025
RMN02917_sante004_prevs

From France to Georgia: Président Cheese Wins the Golden Brand Award

June 14, 2025
TAMTA KALANDADZE, Brand Manager at BMS

Pasta Reggia Expands Its Footprint in Georgian Market with New Products

June 14, 2025
EKA MAGHLAPERIDZE, Head of the Marketing Department at Libo Group

Fino: A Fresh Presence in the Georgian Market

June 14, 2025
KEREM YELSAL, Export Marketing Manager of Betek

Local Focus: Betek’s Strategy for Building Long-Term Value in Georgia’s Construction Industry

June 14, 2025
TAMARA GOGOLADZE, Head of Marketing at Libo Group

Italy’s Pasta del Capitano Expands Influence in Georgia with Innovative Oral Health Solutions

June 14, 2025
ALEKSANDRE OKROSHIDZE, Director of Element Construction

Element Construction Plans to Expand Internationally After Successful Entry to Uzbekistan

June 14, 2025
MARIAM DAVITASHVILI, Founder and Director of Party Lab

Event Planning Company Party Lab Expands with Party Accessories Store

June 14, 2025

LATESTBUSINESS

REVAZ NATROSHVILI, CEO of Proservice

Proservice Launches Cloud Solutions, Expanding Infrastructure with Innovations

by Golden Brand
June 14, 2025
0

ROLAND ERADZE, Founder of Bona Georgia

Bona Georgia Expands with New Showroom and Innovations in Floor Care

by Golden Brand
June 14, 2025
0

Foodmg

The Standard of Excellence in Catering: Food Management Group Wins Golden Brand Award

by Golden Brand
June 14, 2025
0

RMN02917_sante004_prevs

From France to Georgia: Président Cheese Wins the Golden Brand Award

by Golden Brand
June 14, 2025
0

TAMTA KALANDADZE, Brand Manager at BMS

Pasta Reggia Expands Its Footprint in Georgian Market with New Products

by Golden Brand
June 14, 2025
0

EKA MAGHLAPERIDZE, Head of the Marketing Department at Libo Group

Fino: A Fresh Presence in the Georgian Market

by Golden Brand
June 14, 2025
0

KEREM YELSAL, Export Marketing Manager of Betek

Local Focus: Betek’s Strategy for Building Long-Term Value in Georgia’s Construction Industry

by Golden Brand
June 14, 2025
0

TAMARA GOGOLADZE, Head of Marketing at Libo Group

Italy’s Pasta del Capitano Expands Influence in Georgia with Innovative Oral Health Solutions

by Golden Brand
June 14, 2025
0

GET IN TOUCH

Submit guest post/Letters to the Editor:

editor (at) finchannel.com

Sales & Marketing: (+995 558) 03 03 03 Email: marketing (at) finchannel.com

Whatsup: (+995 599) 96 52 52

Georgia:

(+995 599) 96 52 52 Email: editor (@) finchannel.com

Postal address: 17 Mtskheta str. Tbilisi, Georgia 0179 The FINANCIAL

RESOURCE

  • Work at the FINANCIAL
  • ePaper
  • Advertise in The FINANCIAL
  • Access ePaper
  • Guest posts
  • Contributed articles
  • AmericanStockNews
  • Coupon Codes
  • GLOSSY MAG
American Culture Center
ACC Partner

GUIDEBOOK

  • Meet our team
  • Invest in Georgia
  • Become contributor
  • Archive

FOLLOW US

  • Facebook
  • Twitter
  • Google+
  • Youtube
No Result
View All Result
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • Americas
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • lifestyle
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE

© 2025 Intelligence Group llc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.